Condition: Asthma
Interventions: Drug: BIIL 284 BS; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: BIIL 284 BS; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Physiological variables best predict adult asthma phenotypes
News-Medical.net Physiological variables are more consistent predictors of adult asthma phenotypes than inflammatory biomarkers, an international team of researchers suggests. Using data from the Pan-European BIOAIR study, the team found that patients' phenotypes were … |
View full post on asthma – Google News
Physiological variables best predict adult asthma phenotypes
medwireNews medwireNews: Physiological variables are more consistent predictors of adult asthma phenotypes than inflammatory biomarkers, an international team of researchers suggests. Using data from the Pan-European BIOAIR study, the team found that patients' … |
View full post on asthma – Google News